179 related articles for article (PubMed ID: 24300391)
1. Screening and verification of ssDNA aptamers targeting human hepatocellular carcinoma.
Lu B; Wang J; Zhang J; Zhang X; Yang D; Wu L; Luo Z; Ma Y; Zhang Q; Ma Y; Pei X; Yu H; Liu J
Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):128-35. PubMed ID: 24300391
[TBL] [Abstract][Full Text] [Related]
2. Cell-SELEX based selection and characterization of DNA aptamer recognizing human hepatocarcinoma.
Ninomiya K; Kaneda K; Kawashima S; Miyachi Y; Ogino C; Shimizu N
Bioorg Med Chem Lett; 2013 Mar; 23(6):1797-802. PubMed ID: 23403083
[TBL] [Abstract][Full Text] [Related]
3. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.
Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB
Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565
[TBL] [Abstract][Full Text] [Related]
4. Identification of liver cancer-specific aptamers using whole live cells.
Shangguan D; Meng L; Cao ZC; Xiao Z; Fang X; Li Y; Cardona D; Witek RP; Liu C; Tan W
Anal Chem; 2008 Feb; 80(3):721-8. PubMed ID: 18177018
[TBL] [Abstract][Full Text] [Related]
5. Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX.
Xu J; Teng IT; Zhang L; Delgado S; Champanhac C; Cansiz S; Wu C; Shan H; Tan W
PLoS One; 2015; 10(5):e0125863. PubMed ID: 25938802
[TBL] [Abstract][Full Text] [Related]
6. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.
Wang FB; Rong Y; Fang M; Yuan JP; Peng CW; Liu SP; Li Y
Biomaterials; 2013 May; 34(15):3816-27. PubMed ID: 23465488
[TBL] [Abstract][Full Text] [Related]
7. Selection of aptamers for molecular recognition and characterization of cancer cells.
Tang Z; Shangguan D; Wang K; Shi H; Sefah K; Mallikratchy P; Chen HW; Li Y; Tan W
Anal Chem; 2007 Jul; 79(13):4900-7. PubMed ID: 17530817
[TBL] [Abstract][Full Text] [Related]
8. Selection and Characterization of a Novel DNA Aptamer, Apt-07S Specific to Hepatocellular Carcinoma Cells.
Yu XX; Ge KL; Liu N; Zhang JY; Xue ML; Ge YL
Drug Des Devel Ther; 2020; 14():1535-1545. PubMed ID: 32368012
[TBL] [Abstract][Full Text] [Related]
9. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
10. Screening and Identification of ssDNA Aptamer for Human GP73.
Du J; Hong J; Xu C; Cai Y; Xiang B; Zhou C; Xu X
Biomed Res Int; 2015; 2015():610281. PubMed ID: 26583119
[TBL] [Abstract][Full Text] [Related]
11. Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.
Dong L; Tan Q; Ye W; Liu D; Chen H; Hu H; Wen D; Liu Y; Cao Y; Kang J; Fan J; Guo W; Wu W
Sci Rep; 2015 Oct; 5():15552. PubMed ID: 26497223
[TBL] [Abstract][Full Text] [Related]
12. Aptamers: new arrows to target dendritic cells.
Ganji A; Varasteh A; Sankian M
J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
[TBL] [Abstract][Full Text] [Related]
13. Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX.
Li S; Xu H; Ding H; Huang Y; Cao X; Yang G; Li J; Xie Z; Meng Y; Li X; Zhao Q; Shen B; Shao N
J Pathol; 2009 Jul; 218(3):327-36. PubMed ID: 19291713
[TBL] [Abstract][Full Text] [Related]
14. Selection of DNA aptamers against epidermal growth factor receptor with high affinity and specificity.
Wang DL; Song YL; Zhu Z; Li XL; Zou Y; Yang HT; Wang JJ; Yao PS; Pan RJ; Yang CJ; Kang DZ
Biochem Biophys Res Commun; 2014 Oct; 453(4):681-5. PubMed ID: 25242523
[TBL] [Abstract][Full Text] [Related]
15. Cell-SELEX based selection and optimization of DNA aptamers for specific recognition of human cholangiocarcinoma QBC-939 cells.
Wan J; Ye L; Yang X; Guo Q; Wang K; Huang Z; Tan Y; Yuan B; Xie Q
Analyst; 2015 Sep; 140(17):5992-7. PubMed ID: 26181902
[TBL] [Abstract][Full Text] [Related]
16. The application of aptamers in cancer research: an up-to-date review.
Hu M; Zhang K
Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
[TBL] [Abstract][Full Text] [Related]
17. Evolution of a gastric carcinoma cell-specific DNA aptamer by live cell-SELEX.
Cao HY; Yuan AH; Shi XS; Chen W; Miao Y
Oncol Rep; 2014 Nov; 32(5):2054-60. PubMed ID: 25175855
[TBL] [Abstract][Full Text] [Related]
18. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for
Zhang L; Zhou L; Zhang H; Zhang Y; Li L; Xie T; Chen Y; Li X; Ling N; Dai J; Sun X; Liu J; Zhao J; Peng T; Ye M
ACS Appl Mater Interfaces; 2021 Nov; 13(46):54656-54664. PubMed ID: 34779207
[TBL] [Abstract][Full Text] [Related]
19. Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application.
Ikebukuro K; Hasegawa H; Sode K
Nucleic Acids Symp Ser (Oxf); 2007; (51):399-400. PubMed ID: 18029755
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-drug conjugation for targeted tumor cell therapy.
Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
